These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18070941)

  • 21. Evaluation of prognostic scale Thrombolysis In Myocardial Infarction and Killip. An ST-elevation myocardial infarction new scale.
    García-Paredes T; Aguilar-Alonso E; Arboleda-Sánchez JA; Vera-Almazán A; Arias-Verdú MD; Oléa-Jiménez V; Fuset-Cabanes MP; Sánchez-Cantalejo E; Rivera-Fernández R
    Am J Emerg Med; 2014 Nov; 32(11):1364-9. PubMed ID: 25224025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction.
    Björklund E; Stenestrand U; Lindbäck J; Svensson L; Wallentin L; Lindahl B
    Eur Heart J; 2006 May; 27(10):1146-52. PubMed ID: 16624832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.
    Danchin N; Blanchard D; Steg PG; Sauval P; Hanania G; Goldstein P; Cambou JP; Guéret P; Vaur L; Boutalbi Y; Genès N; Lablanche JM;
    Circulation; 2004 Oct; 110(14):1909-15. PubMed ID: 15451803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk factors of short term mortality in patients with acute ST-elevation myocardial infarction complicated with fatal arrhythmia].
    Wang J; Yang YM; Zhu J; Tan HQ; Liu LS;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jul; 41(7):549-58. PubMed ID: 24286357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry).
    Montalescot G; Dallongeville J; Van Belle E; Rouanet S; Baulac C; Degrandsart A; Vicaut E;
    Eur Heart J; 2007 Jun; 28(12):1409-17. PubMed ID: 17412730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ln-hospital mortality after ST-segment elevation myocardial infarction according to reperfusion therapy].
    Prieto JC; Sanhueza C; Martínez N; Nazzal C; Corbalán R; Cavada G; Lanas F; Bartolucci J; Campos P;
    Rev Med Chil; 2008 Feb; 136(2):143-50. PubMed ID: 18483666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary percutaneous angioplasty, thrombolysis and conservative treatment in low-risk patients with ST-elevation myocardial infarction: effects on short- and long-term mortality.
    Grajek S; Araszkiewicz A; Lesiak M; Grygier M; Pyda M; Skorupski W; Mitkowski P; Baszko A
    Kardiol Pol; 2012; 70(1):1-5. PubMed ID: 22267414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.
    Srinivas VS; Cannon CP; Gibson CM; Antman EM; Greenberg MA; Tanasijevic MJ; Murphy S; de Lemos JA; Sokol S; Braunwald E; Mueller HS
    Am Heart J; 2001 Jul; 142(1):29-36. PubMed ID: 11431653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute myocardial infarction network.
    Manari A; Ortolani P; Guastaroba P; Casella G; Vignali L; Varani E; Piovaccari G; Guiducci V; Percoco G; Tondi S; Passerini F; Santarelli A; Marzocchi A
    Eur Heart J; 2008 Aug; 29(15):1834-42. PubMed ID: 18617475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis.
    Mehta RH; Stebbins AS; Lopes RD; Califf RM; Pieper KS; Armstrong PW; Van de Werf F; Hochman JS; White HD; Topol EJ; Alexander JH; Granger CB
    Am J Cardiol; 2012 Feb; 109(3):320-6. PubMed ID: 22078221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delays in fibrinolysis as primary reperfusion therapy for acute ST-segment elevation myocardial infarction.
    Glickman SW; Cairns CB; Chen AY; Peterson ED; Roe MT
    Am Heart J; 2010 Jun; 159(6):998-1004.e2. PubMed ID: 20569712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
    Ke D; Zhong W; Fan L; Chen L
    Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction.
    Wiviott SD; Morrow DA; Frederick PD; Giugliano RP; Gibson CM; McCabe CH; Cannon CP; Antman EM; Braunwald E
    J Am Coll Cardiol; 2004 Aug; 44(4):783-9. PubMed ID: 15312859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of survival after contemporary percutaneous coronary revascularization for acute myocardial infarction in the real world.
    Lee CH; van Domburg RT; Hoye A; Lemos PA; Tanabe K; Smits PC; van der Giessen WJ; de Feyter P; Serruys PW
    J Invasive Cardiol; 2004 Nov; 16(11):627-31. PubMed ID: 15550731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
    Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of age on long-term outcome after emergent percutaneous coronary intervention for ST-elevation myocardial infarction.
    Hiew C; Williams T; Hatton R; Narasimhan S; O'Connor S; Baker F; McElduff P; Attia J; Collins N
    J Invasive Cardiol; 2010 Jun; 22(6):273-7. PubMed ID: 20516507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.
    Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Mark B; Zahn R; Senges J; Gottwik M
    Thromb Haemost; 2008 Jan; 99(1):155-60. PubMed ID: 18217148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction.
    Kent DM; Ruthazer R; Griffith JL; Beshansky JR; Concannon TW; Aversano T; Grines CL; Zalenski RJ; Selker HP
    Am J Cardiol; 2008 Mar; 101(6):790-5. PubMed ID: 18328842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Participation in thrombolytic trials delays reperfusion therapy in acute myocardial infarction.
    Wąsek W; Stec S; Maciejewski P; Kłosiewicz Wąsek B; Bednarz B; Budaj A
    Kardiol Pol; 2012; 70(8):775-80. PubMed ID: 22933207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.